Kalivir Immunotherapeutics, Inc.

Pittsburgh, PA

UEI
XZ76K36KG367
CAGE
Not on record
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
240 Alpha Dr, Pittsburgh, PA 15238, USA
Website
kalivir.com
Founded
2019
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Translation of the novel oncolytic immunotherapy VET6-PDI R44CA314562 National Cancer Institute (NIH) $306,756

Quick answers

Is Kalivir Immunotherapeutics, Inc. registered in SAM.gov?

Yes. Kalivir Immunotherapeutics, Inc.'s SAM.gov registration is active through June 30, 2027.

What is Kalivir Immunotherapeutics, Inc.'s most recent federal award?

Kalivir Immunotherapeutics, Inc.'s most recent federal grant award is Translation of the novel oncolytic immunotherapy VET6-PDI (R44CA314562), from National Cancer Institute (NIH), on September 3, 2026.

On GovTribe

See Kalivir Immunotherapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login